Clinical Trial Update: Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression [NA]

View source ↗

Summary

A completed clinical trial evaluated whether dietary intake of methyl donor nutrients can reduce the risk of progression in non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Fu Jen Catholic University Hospital | Conditions: Non-alcoholic Fatty Liver Disease | NA | Status: COMPLETED